⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Coave Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Coave Therapeutics
↗Paris, France
Coave Therapeutics is a clinical-stage biotechnology company based in Paris, France, focused on developing next-generation gene therapies for rare ocular and central nervous system (CNS) diseases. The company utilizes its proprietary ALIGATER™ (Advanced Vectors-Ligand Conjugates) platform to create precision, ligand-conjugated AAV vectors that improve tissue specificity, safety, and delivery efficiency compared to traditional gene therapy methods.
Coave is expanding its international footprint, including establishing a presence in the Boston biotech hub. The company is backed by prominent life sciences investors and is actively advancing a pipeline of genetic medicines, with a lead program, CoTx-101, targeting retinal vascular diseases through a novel suprachoroidal delivery approach.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$33M
Investors:Novo Holdings A/S, Bpifrance, Invus, UI Investissement, Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, Turenne Capital
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Gene therapy, AAV, Ligand-conjugated vectors
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Academic collaborations with University of Nantes and various gene therapy research centers.
COMPETITION
Position:Emerging
Competitors:RegenxBio, LogicBio Therapeutics, Genethon
LEADERSHIP
Key Executives:
Rodolphe Clerval - CEO
Romain Pettenaro - VP of Business Development
Board Members:Frederic Chereau (Chairman), Olivier Danos, Claudia Mitchell
LINKS
Website:coavetx.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Coave Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.